Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
PLoS One ; 15(2): e0229256, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32084204

RESUMEN

Cigarette smoke (CS) contains multiple gaseous and particulate materials that can cause lung inflammation, and smoking is the major cause of chronic obstructive pulmonary disease (COPD). We sought to determine the mechanisms of how CS triggers lung inflammation. Nur77, a nuclear hormone receptor belonging to the immediate-early response gene family, controls inflammatory responses, mainly by suppressing the NF-κB signaling pathway. Because it is unknown if Nur77's anti-inflammatory role modulates COPD, we assessed if and how Nur77 expression and activity are altered in CS-induced airway inflammation. In lung tissues and bronchial epithelial cells from COPD patients, we found Nur77 was downregulated. In a murine model of CS-induced airway inflammation, CS promoted lung inflammation and also reduced Nur77 activity in wild type (WT) mice, whereas lungs of Nur77-deficient mice showed exaggerated CS-induced inflammatory responses. Our findings in in vitro studies of human airway epithelial cells complemented those in vivo data in mice, together showing that CS induced threonine-phosphorylation of Nur77, which is known to interfere with its anti-inflammatory functions. In summary, our findings point to Nur77 as an important regulator of CS-induced inflammatory responses and support the potential benefits of Nur77 activation for COPD treatment.


Asunto(s)
Regulación hacia Abajo/efectos de los fármacos , Nicotiana/química , Miembro 1 del Grupo A de la Subfamilia 4 de Receptores Nucleares/genética , Enfermedad Pulmonar Obstructiva Crónica/genética , Humo/efectos adversos , Animales , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Humanos , Inflamación/genética , Pulmón/patología , Ratones , Fosforilación/efectos de los fármacos , Enfermedad Pulmonar Obstructiva Crónica/patología , Treonina/metabolismo
2.
Am J Pathol ; 189(3): 482-491, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30414411

RESUMEN

The transcription factor Nur77 belongs to the NR4A subfamily of nuclear hormone receptors. It features an atypical ligand-binding site that precludes canonical ligand binding, leading to the designation orphan nuclear receptor. However, recent studies show that small molecules can interact with the receptor and modulate its activity by inducing a conformational change in the Nur77 ligand-binding site. Nur77 expression and activation are rapidly induced by various physiological and pathologic stimuli. Once expressed, Nur77 initiates transcriptional activity and modulates expression of its target genes. Both in vitro and in vivo evidence shows that Nur77 dampens the immune response to proinflammatory stimuli, such as tumor necrosis factor-α, Toll-like receptor ligands, and oxidized lipids, primarily by suppressing NF-κB signaling. Although studies focusing on Nur77's role in lung pathophysiology are currently incomplete, available data support its involvement in the pathogenesis of lung diseases, including asthma, acute lung injury, and pulmonary fibrosis, and thus suggest a therapeutic potential for Nur77 activation in these diseases. This review addresses the mechanisms that control Nur77 as well as its known roles in inflammation-related lung diseases. Evidence regarding the therapeutic potential of Nur77-targeting molecules will also be presented. Although current knowledge is limited, additional research followed by clinical studies may firmly identify Nur77 as a pharmacologic target for inflammation-related lung diseases.


Asunto(s)
Enfermedades Pulmonares/metabolismo , Pulmón/metabolismo , Miembro 1 del Grupo A de la Subfamilia 4 de Receptores Nucleares/metabolismo , Transducción de Señal , Transcripción Genética , Animales , Humanos , Inflamación/metabolismo , Inflamación/patología , Pulmón/patología , Enfermedades Pulmonares/patología , Enfermedades Pulmonares/terapia , FN-kappa B/biosíntesis , Receptores Toll-Like/biosíntesis , Factor de Necrosis Tumoral alfa/biosíntesis
3.
Am J Physiol Heart Circ Physiol ; 313(3): H524-H545, 2017 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-28626075

RESUMEN

Sex differences between women and men are often overlooked and underappreciated when studying the cardiovascular system. It has been long assumed that men and women are physiologically similar, and this notion has resulted in women being clinically evaluated and treated for cardiovascular pathophysiological complications as men. Currently, there is increased recognition of fundamental sex differences in cardiovascular function, anatomy, cell signaling, and pathophysiology. The National Institutes of Health have enacted guidelines expressly to gain knowledge about ways the sexes differ in both normal function and diseases at the various research levels (molecular, cellular, tissue, and organ system). Greater understanding of these sex differences will be used to steer future directions in the biomedical sciences and translational and clinical research. This review describes sex-based differences in the physiology and pathophysiology of the vasculature, with a special emphasis on sex steroid receptor (estrogen and androgen receptor) signaling and their potential impact on vascular function in health and diseases (e.g., atherosclerosis, hypertension, peripheral artery disease, abdominal aortic aneurysms, cerebral aneurysms, and stroke).


Asunto(s)
Andrógenos/metabolismo , Enfermedades Cardiovasculares/metabolismo , Sistema Cardiovascular/metabolismo , Estrógenos/metabolismo , Hormonas Esteroides Gonadales/metabolismo , Animales , Enfermedades Cardiovasculares/fisiopatología , Enfermedades Cardiovasculares/terapia , Sistema Cardiovascular/fisiopatología , Femenino , Disparidades en el Estado de Salud , Disparidades en Atención de Salud , Humanos , Masculino , Receptores Androgénicos/metabolismo , Receptores de Estrógenos/metabolismo , Factores Sexuales , Transducción de Señal
4.
Nanotoxicology ; 4(1): 42-51, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20795901

RESUMEN

The dispersion in air of nanoparticles of different sizes, materials and morphologies with controlled agglomeration involving aerosol delivery for in vivo and in vitro studies is one of the most difficult challenges in the field of nanoparticle toxicology. We describe here a nanoparticle dispersion system using an electrospray method to deliver airborne nanoparticles (approximately 10-100 nm) with spatial uniformity and controllable particle concentration for in vitro and in vivo studies. With the dispersion method, single nanoparticles (polystyrene latex particles, TiO(2), Au, Mn, quantum dots, and carbon nanotubes) can be delivered to cells and animals via the air. The degree of agglomeration can be controlled by changing the suspension feeding rate to simulate realistic conditions for exposure studies.


Asunto(s)
Aerosoles/toxicidad , Técnicas Electroquímicas , Nanopartículas/toxicidad , Nanotubos de Carbono/toxicidad , Aerosoles/química , Animales , Técnicas Electroquímicas/instrumentación , Técnicas Electroquímicas/métodos , Humanos , Exposición por Inhalación , Tamaño de la Partícula , Ratas
5.
J Cell Biochem ; 104(4): 1172-80, 2008 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-18247342

RESUMEN

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily. TRAIL shows strong cytotoxicity to many cancer cells but minimal cytotoxicity to most normal cells. Interestingly, our recent studies have demonstrated that pretreatment with TRAIL induces acquired resistance to TRAIL (Song et al. 2007 J Biol Chem 282: 319). Acquired TRAIL resistance develops within 1 day and gradually decays within 5 days after TRAIL treatment. In our current study, we examined whether human colorectal carcinoma CX-1 cells with acquired TRAIL resistance are resistant to UV irradiation as well. CX-1 cells were treated with 200 ng/ml TRAIL for 6 h and incubated various times (0.25-5 days) and then challenged to UV irradiation. Unexpectedly, we observed an increase in apoptosis in acquired TRAIL resistant cells after UVC as well as UVB exposure. This was due to an increase in caspase activation which was mediated through cytochrome c release. These results suggest that cells with acquired TRAIL resistance are sensitive to UV irradiation.


Asunto(s)
Apoptosis/efectos de la radiación , Neoplasias Colorrectales/terapia , Resistencia a Antineoplásicos , Ligando Inductor de Apoptosis Relacionado con TNF/farmacología , Rayos Ultravioleta , Apoptosis/efectos de los fármacos , Caspasas/metabolismo , Línea Celular Tumoral , Neoplasias Colorrectales/patología , Citocromos c/metabolismo , Humanos , Ligando Inductor de Apoptosis Relacionado con TNF/uso terapéutico , Terapia Ultravioleta
6.
J Air Waste Manag Assoc ; 57(12): 1447-51, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18200929

RESUMEN

This study investigated the reforming characteristics and optimum operating condition of the high-temperature plasma torch (so called plasmatron) for hydrogen-rich gas (syngas) production. At the optimum condition, the composition of produced syngas was 45.4% hydrogen (H2), 6.9% carbon monoxide (CO), 1.5% carbon dioxide (CO2), and 1.1% acetylene (C2H2). The H2/CO ratio was 6.6, hydrogen yield was 78.8%, and the energy conversion rate was 63.6%. To obtain the optimum operating condition, parametric studies were carried out examining the effects of O2/CH4 ratio, steam/CH4 ratio, and Ni catalyst addition in reactor. When the steam/CH4 ratio was 1.23, the production of hydrogen was maximized and the methane conversion rate was 99.7%. The syngas composition was determined to be 50.4% H2, 5.7% CO, 13.8% CO2, and 1.1% C2H2. The H2/CO ratio was 9.7, hydrogen yield was 93.7%, and the energy conversion rate was 78.8%. Hydrogen production with catalyst was effective, compared with no catalyst.


Asunto(s)
Calor , Hidrógeno/química , Metano/química , Fuentes de Energía Bioeléctrica , Catálisis , Conservación de los Recursos Energéticos , Eliminación de Residuos , Vapor , Volatilización
7.
FEMS Microbiol Lett ; 227(2): 183-8, 2003 Oct 24.
Artículo en Inglés | MEDLINE | ID: mdl-14592707

RESUMEN

To enhance our understanding of the cytokinesis, we have carried out a genetic screen for temperature-sensitive Schizosaccharomyces pombe mutants that show defects in septum formation and cell division. Here we present the isolation and characterization of a new temperature-sensitive mutant, sun1 (septum uncontrolled), which undergoes uncontrolled septation during cell-division cycle at restrictive temperature (37 degrees C). In sun1 mutant, the actin ring and septum are positioned at random locations and angles, and the nuclear division cycle continues. These observations suggest that the sun1 gene product is required for the proper placement of the actin ring as well as precise septation. In a screen for the sun1(+) gene to complement the sun1 mutant, we have isolated a mad1(+) (mitotic arrest deficient) gene, which encodes a component of the spindle checkpoint in the cell-division cycle. Analysis of crossing the sun1 cell with the mad1(+) null mutant indicates that mad1(+) suppresses the sun1 mutant defective in controlled septation in a cell-division cycle.


Asunto(s)
Actinas/genética , Proteínas Portadoras , Proteínas Nucleares/genética , Fosfoproteínas/genética , Proteínas Represoras/genética , Schizosaccharomyces/genética , Actinas/metabolismo , Secuencia de Aminoácidos , Proteínas de Ciclo Celular , División Celular/genética , Datos de Secuencia Molecular , Mutación , Proteínas Nucleares/metabolismo , Fosfoproteínas/aislamiento & purificación , Proteínas de Unión al ARN , Proteínas Represoras/aislamiento & purificación , Proteínas Represoras/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Schizosaccharomyces/citología , Schizosaccharomyces/crecimiento & desarrollo , Proteínas de Schizosaccharomyces pombe , Huso Acromático/metabolismo , Temperatura
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA